A powerful new tool developed in Australia will enable clinicians worldwide to assess an individual’s genetic risk for primary open angle glaucoma with unprecedented accuracy. Already in use in Australia and New Zealand, the polygenic risk score (PRS) analysis developed by Seonix Bio, represents a major leap forward in personalised
Eye care professionals play a pivotal role in ensuring optimal vision correction for patients, and sun protection is no exception. The world of sunwear is constantly evolving, with cutting-edge technologies offering solutions tailored to your patients’ specific needs.
